Susquehanna International Group, LLP Immuneering Corp Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$1.28 - $2.75 $113,607 - $244,079
88,756 New
88,756 $113,000
Q4 2023

Feb 14, 2024
BUY
$4.84 - $8.44 $51,318 - $89,489
10,603 New
10,603 $77,000
Q1 2023

May 16, 2023
BUY
$3.78 - $10.38 $48,947 - $134,410
12,949 Added 28.78%
57,949 $562,000
Q4 2022

Feb 14, 2023
BUY
$4.09 - $15.0 $184,050 - $675,000
45,000 New
45,000 $218,000

Others Institutions Holding IMRX

# of Institutions
41
Shares Held
4.64M
Call Options Held
0
Put Options Held
0
View Full List

About Immuneering Corp

IMRX Quotes by TradingView
  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $49.9M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email